Cidara Therapeutics is Biotechnology in United States that focus on Cidara Therapeutics Inc business. Founded in 2013. They cover business area such as Cidara Therapeutics Inc, development, commercialization, infective, prevention, disease, a novel molecule, antifungal, rezafungin, serious, invasive fungal infection, high mortality rate, its other product candidate, RSV AVC, HIV AVC.
2013
( 11 years old in 2024 )
Cidara Therapeutics Inc
-
6310 Nancy Ridge Drive
Suite 101
San Diego, CA 92121
United States
Private
Cidara Therapeutics Incdevelopmentcommercializationinfectivepreventiondiseasea novel moleculeantifungalrezafunginserious, invasive fungal infectionhigh mortality rateits other product candidateRSV AVCHIV AVC
* We use standard office opening hours in near Cidara Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Cidara Therapeutics is Biotechnology business from United States that founded in 2013 (11 years old in 2024), Cidara Therapeutics business is focusing on Cidara Therapeutics Inc.
Cidara Therapeutics headquarter office and corporate office address is located in 6310 Nancy Ridge Drive Suite 101 San Diego, CA 92121 United States.
Cidara Therapeutics was founded in United States.
In 2024, Cidara Therapeutics is currently focus on Cidara Therapeutics Inc sector.
Above is snippet of Google Trends for "Cidara Therapeutics Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Cidara Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
